NEU 2.67% $14.56 neuren pharmaceuticals limited

Neuren Media and Analyst Coverage, page-1223

  1. 1,417 Posts.
    lightbulb Created with Sketch. 316
    Hi @hottod,

    I also reckon Ch18 conditions (including monosomy, trisomy (Edwards), p- and other) would not only meet the orphan criteria and also could benefit favourably from NEU attention and NNZ2591.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.